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Purpose or Objective: Microbeam Radiation Therapy (MRT) is 
a relatively new approach in radiation oncology exploiting 
the dose-volume effect by using orthovoltage X-rays on a 
microscopic scale [1]. Arrays of plane parallel beams of 
typically 50 µm width with spacings of a few hundred µm 
show extraordinary normal tissue sparing, while still being 
capable to ablate tumours in preclinical research [2].  
Organ motion has not been an issue in MRT, as long as 
preclinical research was carried out in small samples, such as 
cell cultures and rodents. The possible future treatment of 
human brain tumours using microbeam radiation however 
may be affected by cardio-synchronous tissue pulsation. This 
pulsation, with amplitudes in the order of 100 µm [3], 
induces translational movements of the brain tissue causing a 
blurring of the planned plane-parallel dose pattern of 
microbeams in case of extended exposure times. 
 
Material and Methods: A Monte Carlo study to quantify these 
effects was performed using the Geant4 toolkit. Dose was 
scored in a homogeneous cubic water phantom of 15 cm size 
on a grid with 5 µm resolution perpendicular to the beam. 
The sensitive volume was chosen to have an extension of 1 
mm along the beam direction in 20 mm depth from the 
surface, which corresponds to the reference dosimetry 
conditions in MRT. The relative statistical uncertainty of the 
dose (1 standard deviation) per voxel was between 1% and 
1.5% in the peak region and between 6% and 9% in the dose 
valley, depending on the evaluated beam configuration and 
could be further reduced by appropriate binning of the raw 
data. 
 
Results: Monte Carlo calculations for different geometrical 
microbeam configurations and employed dose rates revealed 
significant changes of the planned dose patterns when 
compared to the static case. The chosen quality indicators of 
our study like peak dose, peak-to-valley dose ratio (PVDR), 
microbeam width, spacing, and penumbra were observed to 
be highly degraded, e.g. the PVDR being reduced by up to 
35%. 
 
Conclusion: We have demonstrated that the effect of even 
small organ motions occurring at heart rate frequencies in 
the brain can only be tolerated at high dose rates of approx. 
10 Gy/s. For example, a dose rate of 12.3 kGy/s can be given 
as a threshold value if one wants to apply a high peak 
entrance dose of 300 Gy in 3 mm depth for 50 µm wide 
microbeams and a primary beam size of 500 µm 
perpendicular to the scan direction. For lower dose rates the 
observed deterioration of the microbeam dose patterns is 
likely to destroy the intended dose sparing effect for healthy 
tissues. 
For interlaced microbeam geometries an appropriate gating 
technique could be applied in the future based on the phase 
of the cardiac cycle. 
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Purpose or Objective: Deep-inspiration breath-hold (DIBH) 
mitigates the breathing motion, and thereby reduces the 
treated volume. This yields less dose to adjacent organs-at-
risk, and enables dose escalated radiotherapy of locally 
advanced non-small cell lung cancer (NSCLC) patients. 
However, DIBH can potentially introduce an extra uncertainty 
as reproducibility of DIBH can be affected by e.g. arching or 
unwanted motion during inspiration. This study was designed 
to investigate the feasibility and geometrical reproducibility 
of the anatomy, when utilizing DIBH in radiotherapy of locally 
advanced NSCLC patients. 
 
Material and Methods: Seventeen NSCLC patients scheduled 
for curative radiotherapy were enrolled. One 4DCT in free-
breathing (FB) and one 3DCT in DIBH, both with intravenous 
contrast, were acquired prior to (pre), in the middle of 
(mid), and after (post) the course of treatment. 
Furthermore, cone-beam CTs (CBCTs) both in FB and DIBH 
were acquired weekly throughout the course of treatment. A 
marker-based optical breathing signal (RPM, Varian Medical 
Systems, CA, USA) was utilized both for phase sorting into 10 
phases during 4DCT and for visual guidance in DIBH 
3DCT/CBCT. Changes in relative lung volumes (DIBH over FB) 
and in gross tumor volumes (GTVs) over the course of 
treatment were analyzed. Furthermore, the feasibility of 
DIBH for locally advanced NSCLC patients was analyzed based 
on the average breath-hold times and average number of 
breath-holds required to complete a CBCT acquisition. 
 
Results: Compared to FB, the total lung volume increased in 
DIBH by, on average, a factor of 1.84, 1.81 and 1.86 for the 
pre, mid and post treatment scans, respectively. A 
correlation between relative total lung volume (DIBH/FB) and 
mean amplitude during DIBH CT was observed (Figure 1). No 
statistically significant changes in lung volume during the 
courses of treatment were discovered. In the middle of the 
treatment course the GTV had decreased with 34 % and 26 %, 
while at the end of treatment the decrease from the original 
GTV was 42 % and 43 % for DIBH and FB, respectively. On 
average 2.1 breath-holds, with an average breath-hold time 
of 43 seconds, were required for a patient to complete a 
DIBH CBCT acquisition. However, among the patients this 
varied between 1 to 11 breath-holds with breath-hold times 
ranging from 4 to 74 seconds. For each patient, no 
statistically significant changes in breath-hold times or 
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number of breath-holds required were observed during the 
courses of treatment. 
 
 
 
Conclusion: Breath-hold capabilities are highly individual and 
generally not observed to be changing during the course of 
treatment. The ratio between DIBH and FB total lung volume 
was observed to be stable during the course of treatment, 
while systematic decreases in GTV were observed both in 
DIBH and FB. DIBH radiotherapy of locally advanced NSCLC 
patients is considered to be feasible with geometrical 
reproducibility. 
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Purpose or Objective: The aim of radiotherapy is accurate 
delivery of dose to target volumes within a patient, while 
minimizing dose to the surrounding healthy tissue. 
Respiratory motion is still a significant problem in many 
radiotherapy treatments. Recent developments in the 
treatment of breast cancer have focused on “gating” the 
delivery of the treatment beams. With this technique, the 
effect of patient motion during treatment is reduced and the 
separation between the target volume and organs at risk 
(OAR) increased. Rapidly switching the treatment beam on or 
off, depending on the patient breathing cycle is the basic 
principle of gating. It is therefore important that the 
characteristics of gated treatments such as latency are 
known. 
 
Material and Methods: For this study, an in-house built 
electrical PIN diode circuit was designed to function as a tool 
for quality assurance (QA). Beam latency timing properties 
were measured on a TrueBeam™ (Varian, Palo Alto) linear 
accelerator and its internal gating system. Pulses of 
radiation, triggered within a predefined gating window, were 
measured with the PIN diode and the results compared to 
measurements of current through the linac target. A phantom 
consisting of the electrical circuit coupled to a moving stage 
was used to simulate a binary pattern to produce fast beam 
triggering. Processing of the beam pulses and calculation of 
the latency timings was performed by an Atmega328P 
microcontroller (MCU). All measurements were performed 
with photon energies 6MV and 10MV and a dose rate of 
600MU/min (equivalent to a reference dose in water of 6 
Gy/min). For every measurement, a total of 50 data points 
were collected and the results compared by calculating the 
arithmetic mean value and the standard deviation.  
 
 
Results: The results of the beam latency measurements are 
shown in the table below. 
 
Beam on 
latency (ms)  
Beam off 
latency (ms)  
Energy Target I PIN diode Target I PIN diode 
6 MV 2.13 ±1.15 2.11 ±1.05 57.33 ±10.01 57.69 ±9.59 
10 MV 2.15 ±1.06 2.12 ±1.09 56.01 ±10.10 57.73 ±10.06 
 
Conclusion: Measuring beam gating latencies of a linear 
accelerator via beam pulse analyses with the help of a PIN 
diode and the in-house built electrical circuit is a useful 
method in good agreement with measurements from the 
accelerator target current signal. The PIN diode circuit 
provided a good response when using different beam energies 
and can be a useful tool to perform QA on different types of 
linear accelerators and gating systems. This could potentially 
lead to improvements in the gated radiotherapy treatments. 
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Purpose or Objective: Respiration motion during 
radiotherapy of breast cancer patients will perturb the 
delivered dose. The accuracy of the delivered dose can be 
measured by in vivo EPID dosimetry. The respiration motion 
can be reduced by use of the Active Breathing Coordinator 
(ABC) produced by Elekta. This study investigates whether a 
difference in EPID measured acceptance pass rate is 
associated to the use of ABC and whether the residual 
breathing variation while using the ABC system is associated 
to the measured pass rate. 
 
Material and Methods: 15 ABC and 10 non-ABC breast cancer 
patients were monitored by EPID dosimetry for up to five 
fractions during the treatment. In total 185 and 82 tangential 
fields were available for analysis for ABC and non-ABC 
groups, respectively. The in vivo EPID dosimetry system 
(Wendling et al. Med Phys 2006) back projects the dose to a 
plane parallel to the EPID panel that includes the prescription 
point. The dose is compared to the planned distribution using 
a gamma analysis (3%, 3mm) and defines the pass rate as the 
fraction of gamma values less than one. Since pass rates are 
not normally distributed comparison between the ABC and 
non-ABC group was performed by a Mann-Whitney U test. The 
ABC system measured the amount of actual inhaled air at 
each treatment session and during the treatment planning 
CT. At breath-holds during treatment, deviation in inhaled air 
